Leaderboard

En | De
No articles selected!     View Cart  
You are here: Oncology 11. March 2026
Search
medline.ch
Oncology
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 95830  Previews Next
   
   Articles 1 - 20 / 1916592  
   
Treatment Patterns and Clinical Outcomes in Metastatic HR+/HER2- and Triple-Negative Breast Cancer in Canada: The HER2- TRENDS Study.
Adv Ther
Gambaro K, Rachedi K, Basik M, Batist G, Saad F, Hassan S, Mes-Masson AM, Boudreau D, Vincent F, St-Hilaire E, Mackay H, Abdelsalam M, Yip SM, Hanel R, Shokar S, Senhaji Mouhri Z, Badin M, Klein-Panneton K, Awan AA, Marques M.
PMID: 41806276 [PubMed - as supplied by publisher]


Efficacy of an Online Meaning-Centered Psychotherapy in Caregivers of Advanced Cancer (eMCP-C): A Mixed-Method Pilot Randomized Controlled Trial.
Psychooncology
Takemura N, Li AC, Chan WL, Yu SF, Lou VW, Fong DY, Lee JKQ, Yorke J, Applebaum AJ.
PMID: 41806269 [PubMed - in process]


Cluster analysis of global research hotspots and thematic evolution in breast cancer and general anesthesia a bibliometric study from 1985 to 2024.
Discov Oncol
Wu Q, Deng C, Zhang P.
PMID: 41806251 [PubMed - as supplied by publisher]


First-line treatment efficacy and prognostic model in RAS-mutant metastatic colorectal cancer: a real-world study.
Clin Transl Oncol
Yin W, Wu X, Li T, Yuan Z, Qin L, Li Q.
PMID: 41806240 [PubMed - as supplied by publisher]


Prognostic prediction and immune microenvironment analysis in colorectal cancer using exosome-related lncRNA signatures.
Discov Oncol
Li H, Huang X, Luo Z, Zhou F, Deng Y, Tan C, Jin Y, Yan J, Xiao G.
PMID: 41806199 [PubMed - as supplied by publisher]


Interleukin-1 receptor type 1 in pancreatic cancer progression and metastasis: a review.
Int J Clin Oncol
Saito K, Matsuo Y, Denda Y, Nonoyama K, Murase H, Kato T, Yamakawa Y, Sato T, Sagawa H, Ogawa R, Takiguchi S.
PMID: 41806197 [PubMed - as supplied by publisher]


Social inequalities in cancer in Germany: a call to action.
J Cancer Res Clin Oncol
Sibert NT, Wellbrock M, Bedir A, Grundmann N, Herrmann M, Hoebel J, Jansen L, Popova V, Schwettmann L, Arndt V, Brand T, Gude AC, Hoe C, Hübner J, Lückemeyer M, Mons U, Dalton SO, Voigtländer S, Erdmann F.
PMID: 41806187 [PubMed - in process]


In Vivo Target Drug Enrichment Based on Spatiotemporal Acoustic Node Modulation (STANM) for Bladder Cancer Treatment.
Adv Mater
Su Y, Wu J, Deng Z, Luo Y, Yin Q, Chen K, Liu X, Gao Q, Zhang W, Wang L, Ma Z, Zheng Y.
PMID: 41806148 [PubMed - as supplied by publisher]


Advancements and innovations in the molecular mechanisms and treatment of colorectal cancer.
Discov Oncol
Wang X, Yang J.
PMID: 41806134 [PubMed - as supplied by publisher]


Metabolic reprogramming in cancer: dysregulation of glucose, lipid, and amino acid pathways and therapeutic opportunities.
Mol Biomed
Yu M, Yang D, Chen X, Yang Y, Zhang B, Jiang X, Xing L, Yang Y, Sun Y, Li N.
PMID: 41806079 [PubMed - in process]


AI-powered radiogenomics: imaging-driven diagnosis and discovery of cancer's molecular and cellular landscape.
Mol Genet Genomics
Qiu HF, Zhu JK.
PMID: 41806059 [PubMed - in process]


Neonatal primary pulmonary neoplasms, clinical, imaging, and differential diagnosis.
Pediatr Radiol
Newman B.
PMID: 41805992 [PubMed - as supplied by publisher]


How exclusion criteria can hinder eligibility for lung cancer studies among different racial and ethnic groups.
PLOS Digit Health
Kim JY, Dirks A, Ford RM, Pai L, Ludwig C, Tapan U.
PMID: 41805924 [PubMed]


HIF-2α Inhibitor Combinations Knock Back Kidney Cancer in Two Trials.
Cancer Discov

PMID: 41805886 [PubMed - as supplied by publisher]


Accuracy and reproducibility of tumor size measurement using a deep-learning-based CDSS in resected lung cancer.
PLoS One
Kim EY, Kim JS, Jin KN, Cho YJ, Kim JY.
PMID: 41805778 [PubMed - in process]


A pruned and parameter-efficient Xception framework for skin cancer classification.
PLoS One
K, Do.
PMID: 41805755 [PubMed - in process]


Prevalence of medication-related problems and its predictors among cancer patients in Ethiopia: A systematic review and meta-analysis.
PLoS One
Yismaw MB, Tafere C, Tefera BB, Yehualaw A, Demsie DG, Feyisa K, Debasu Addisu Z, Agmassie Z, Aschale E, Zeleke TK, Abebe RB, Bogale EK, Kefale B.
PMID: 41805738 [PubMed - in process]


Breast Cancer Screening Knowledge and Sentiments in Singaporean Women: Mixed Methods Study Using Topic Modeling, Sentiment Analysis, and Structured Questionnaire Data.
J Med Internet Res
Ho PJ, Lim ZL, Liu J, Mohamed Riza NK, Chew YJ, Lim YY, Tan HL, Goh SA, Oh HB, Chin CH, Kwek SC, Zhang ZP, Ong DLS, Quek ST, Wijerathne S, Iau PTC, Hartman M, Li J.
PMID: 41805687 [PubMed - in process]


Is Functional Reconstruction Feasible With Modified Hip Transposition Using a Customized 3D-printed Femoral Prosthesis After Pelvic Tumor Resection? A Preliminary Study.
Clin Orthop Relat Res
Wang H, Shen J, Zuo D, Liu K, Sun W.
PMID: 41805647 [PubMed - as supplied by publisher]


(Un-)Known Chances: Emerging Hope for Cancer of Unknown Primary - Highlights from ESMO 2025 and the first International Cancer of Unknown Primary Meeting.
Oncol Res Treat
Haas M, Hempel L, Krämer A, Hübner G.
PMID: 41805644 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 1916592    Page 1 of 95830  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1